Search

Author/Creator Hochhaus, A.

1. P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIAL MPNSG-0212: RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA. (23rd June 2022)

Authors:
Stegelmann, F.; Jahn, E.; Koschmieder, S.; Heidel, F.; Hochhaus, A.; Hebart, H.; Isfort, S.; Reiter, A.; Bangerter, M.; Waller, C. F.; Wolleschak, D.; Scheid, C.; Göthert, J.; Schafhausen, P.; Kindler, T.; Radsak, M. P.; Gattermann, N.; Möhle, R.; von Bubnoff, N.; Schrade, A.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
945
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P704: ASCIMINIB PROVIDES DURABLE MOLECULAR RESPONSES IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) WITH THE T315I MUTATION: UPDATED EFFICACY AND SAFETY DATA FROM A PHASE I TRIAL. (23rd June 2022)

Authors:
Hughes, T.; Cortes, J. E.; Réa, D.; Mauro, M. J.; Hochhaus, A.; Kim, D.-W.; Sasaki, K.; Lang, F.; Heinrich, M. C.; Breccia, M.; Deininger, M.; Goh, Y.-T.; Janssen, J. J.; Talpaz, M.; Gómez García de Soria, V.; le Coutre, P.; Kapoor, S.; Cacciatore, S.; Polydoros, F.; Agrawal, N.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
599
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P707: DOSE MODIFICATION DYNAMICS OF PONATINIB IN PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) FROM THE PACE AND OPTIC TRIALS. (23rd June 2022)

Authors:
Apperley, J.; Kantarjian, H.; Deininger, M.; Abruzzese, E.; Cortes, J.; Chuah, C.; DeAngelo, D. J.; DiPersio, J.; Hochhaus, A.; Lipton, J.; Nicolini, F.; Pinilla-Ibarz, J.; Rea, D.; Rosti, G.; Rousselot, P.; Mauro, M.; Shah, N.; Talpaz, M.; Vorog, A.; Ren, X.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
602
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. PB1902: ASC4OPT TRIAL IN PROGRESS: A PHASE 3B OPEN-LABEL OPTIMIZATION STUDY OF ORAL ASCIMINIB IN CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE PREVIOUSLY TREATED WITH 2 OR MORE TYROSINE KINASE INHIBITORS. (23rd June 2022)

Authors:
Breccia, M.; Turkina, A.; Boquimpani, C.; Chuah, C.; Sharf, G.; Schuld, P.; Hoch, M.; Yssel, J.; Zhang, Y.; Hochhaus, A.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1781
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. PB1904: TRIAL IN PROGRESS: A PHASE III STUDY OF ASCIMINIB VS AN INVESTIGATOR-SELECTED TKI IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP). (23rd June 2022)

Authors:
Hughes, T.; Cortes, J.; Takahashi, N.; Larson, R.; Issa, G.; Bombaci, F.; Ramscar, N.; Kapoor, S.; Ifrah, S.; Hochhaus, A.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1783
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Phase 2 study of subcutaneous omacetaxine mepesuccinate for chronic‐phase chronic myeloid leukemia patients resistant to or intolerant of tyrosine kinase inhibitors. Issue 5 (7th March 2013)

Authors:
Cortes, J.; Digumarti, R.; Parikh, P.M.; Wetzler, M.; Lipton, J.H.; Hochhaus, A.; Craig, A.R.; Benichou, A.‐C.; Nicolini, F.E.; Kantarjian, H.M.
Journal:
American journal of hematology
Issue:
Volume 88:Issue 5(2013:May)
Page Start:
350
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. S155: EFFICACY AND SAFETY RESULTS FROM ASCEMBL, A PHASE 3 STUDY OF ASCIMINIB VS BOSUTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE AFTER ≥2 PRIOR TYROSINE KINASE INHIBITORS: WK 96 UPDATE. (23rd June 2022)

Authors:
Rea, D.; Hochhaus, A.; Mauro, M. J.; Minami, Y.; Lomaia, E.; Voloshin, S.; Turkina, A.; Kim, D.-W.; Apperley, J. F.; Cortes, J. E.; Abdo, A.; Fogliatto, L. M.; Kim, D. D. H; le Coutre, P.; Saussele, S.; Annunziata, M.; Hughes, T. P.; Chaudhri, N.; Chee, L.; García-Gutiérrez, V.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
56
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search